NRG Oncology Biospecimen Bank for Cancer Patients
Official title: NRG Oncology Biospecimen Bank
Funded at Nrg Oncology Foundation, INC. · NIH-11512844 · Data updated 2026-11-12
A national cancer research program will collect, store, and link tumor and normal tissues with patient data to support advancing cancer treatments for adults.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nrg Oncology Foundation, INC. NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | April 1, 2026 |
| Project end | March 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $4,476,448 |
| NIH project number | 3U24CA196067-11S1 |
| Project ID | NIH-11512844 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with non-hematologic cancers who participate in NRG/NCORP clinical trials and contribute biospecimens and clinical data.
✕Less likely to help
Patients who do not participate in trials or who do not provide biospecimens may not directly benefit, though the shared resources could still advance general knowledge.
What this research studies
This grant supports the NRG Oncology Biospecimen Bank, which collects and preserves biospecimens from adults with solid tumors enrolled in cancer trials. The bank links these samples to rich clinical and epidemiologic data to enable translational research and better understanding of treatment outcomes. Researchers will use standardized processing and annotation to create a high-quality resource that can drive new discoveries and improve future therapies for adults with cancer. The program emphasizes collaboration across multiple institutions to maximize the impact on patient care.
Why it matters
Potential benefit: If successful, patients could benefit from faster development of personalized cancer treatments and better understanding of how different factors affect outcomes.
How similar studies have gone: NRG-BB has a strong track record with millions of biospecimens and numerous publications supporting translational cancer research.
Where this research is happening
-
Nrg Oncology Foundation, INC.
Philadelphia, United States Active
Researchers
- Principal investigator: Simko, Jeff P — Nrg Oncology Foundation, INC.
- Study coordinator: Simko, Jeff P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.